VCs Clash on AI Labs' Secondary Bans and Startup Die-Off

This Week in Startupsgo watch the original →

AI giants like Anthropic and OpenAI void unauthorized SPVs to control cap tables, while panel warns Claude/OpenAI could kill 50% of SaaS startups, prompting one founder to return $15M funding.

Secondary Market Crackdown: Controlling the Wild West

Anthropic and OpenAI issued stark policies voiding unauthorized secondary stock sales, explicitly calling out platforms like Hiive, Forge, Sydecar, and Upmarket. Panelists agreed this targets predatory multi-layer SPVs with 5-10% load-in fees that dilute founder control and create cap table chaos. Dave McClure (Practical VC) predicted lawsuits as investors demand fees back, distinguishing authorized single-layer SPVs (still viable for organized liquidity) from fraudulent schemes: "A surgical scalpel is a tool and a weapon—just depends how you use it." Jenny Fielding (Everywhere Ventures) highlighted unsolicited broker spam preying on founders, while Sam Lessin (Slow Ventures) noted historical precedents at Facebook and Twitter, where controlled processes prevented 'backdoor' entries by rivals. Jason Calacanis criticized companies for enabling SPVs to boost valuations and employee liquidity, only to reverse when fees cut into their share: "That's our money—that 10% loading fee should be going to us."

Divergence emerged on market impact: McClure saw broad disruption beyond AI labs (SpaceX volume dominant), but defended SPVs for capital raising when authorized. Lessin argued accreditation inflation (now 7-8% of population) mitigates access issues, countering Calacanis' push for SEC 'sophisticated investor test' like a driver's exam. Consensus formed around Naval Ravikant's USVC closed-end fund as a compliant workaround, reducing pressure on direct secondaries.

AI's Startup Apocalypse: 50% Attrition Rate

The panel grappled with AI labs commoditizing SaaS moats, citing a real case of a founder returning a $15M Series A six months post-close because Claude would "displace the product and erode value." Calacanis framed the dilemma: grind 10-15 years at a zombie startup with uncertain outcomes, or take guaranteed $10-30M OpenAI packages? Fielding estimated only 50% of portfolio companies survive the SaaS-to-agentic shift, lacking AI-era cash flow machines. McClure echoed fears of job/economy disruption driving demand for AI stock ownership: "Who wouldn't want a piece of the thing that might take their job?"

Agreement on AI's zero-sum dynamics: labs like OpenAI compound capital rather than redistribute via IPOs, unlike Cerebras (raised IPO guidance) or Fervo Energy ($27/share upsized public debut), which offer minimal liquidity. Lessin questioned if SpaceX/Anthropic/OpenAI IPOs would recycle capital to new ventures or entrench winners. Calacanis predicted consolidation, with founders pivoting aggressively or returning funds ethically when tech shifts render products obsolete.

Founder Liquidity vs. Control: Pro-Rata Wars and Pivots

Pro-rata rights sparked tension: Series A VCs squeezing seed investors out, mirroring secondary battles. Fielding advocated returning capital as honorable if AI obsoletes the thesis, avoiding 'zombie' drags. McClure highlighted OpenAI's $6.6B tender enabling employee exits amid SF cost-of-living crises (Shruti Gandhi's viral tweet cited). Intercom's rebrand to AI-first 'Fin' exemplified late-stage pivots, with panelists debating storage of wealth in 'stories' (narratives) over cash flows.

Predictions diverged: McClure foresaw schlocky brokers fleeing as fees evaporate; Fielding urged cap table hygiene; Lessin bet on inflation-eroded accreditation thresholds easing access organically. All concurred on broken U.S. accreditation (only 6% participate despite 30% interest), pushing SEC reforms.

Notable Quotes

  • Jason Calacanis: "People don't want to talk about it because it's scary... a founder closed a $15M Series A... then plan to return the cash because Claude will displace the product."
  • Jenny Fielding: "Probably 50% of portfolio companies that I think might make it—it might not be the money-printing free cash flow machine."
  • Dave McClure: "There's going to be a fuckload of lawsuits... 10% fees brings out these schlocky sales, Wolf of Wall Street types."
  • Sam Lessin: "When Facebook went public it was worth $100B—now that's an A-round."
  • Jason Calacanis: "Storing wealth in stories vs. cash flows."

Key Takeaways

  • Avoid unauthorized multi-layer SPVs; stick to company-approved single-layer for liquidity without cap table pollution.
  • Push for SEC sophisticated investor test to democratize access beyond inflated accreditation thresholds.
  • Founders: Pivot ruthlessly or return capital if AI (e.g., Claude) obsoletes your product—don't run zombies.
  • Expect lawsuits from voided Anthropic/OpenAI trades; brokers with 5-10% fees hit hardest.
  • AI labs compound capital via tenders, not IPOs—bet on winners like OpenAI over broad SaaS survival (50% attrition).
  • Use closed-end funds like USVC as SPV alternatives amid crackdowns.
  • Monitor pro-rata battles: Seed investors vulnerable to later-stage squeezes.
  • Wealth in tech: Prioritize narratives and control over pure cash flow liquidity.
  • #news
  • #rant

summary by x-ai/grok-4.1-fast. probably wrong about something. check the source.